Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-10-30Clinical Trial Update: Study Evaluating Efficacy and Safety of Capmatinib in Combination With Osimertinib in Adult Subjects With Non-small Cell Lung Cancers as Second Line Therapy [Phase 3]
Phase 3 trial evaluating capmatinib with osimertinib in second-line non-small cell lung cancer was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2023-10-25Clinical Trial Update: A Phase I/II Study of Ibrutinib in Previously Treated Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Phase I/II study of ibrutinib in previously treated EGFR-mutant non-small cell lung cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-10-24Clinical Trial Update: A Clinical Trial of Durvalumab (MEDI4736) as 1st Line Therapy in Advanced Non-small Cell Lung Cancer Patients [Phase 2]
A Phase 2 clinical trial evaluating durvalumab (MEDI4736) as first-line therapy in advanced non-small cell lung cancer has completed with re…
-
CLINICAL_TRIALS trial_result · 2023-10-23Clinical Trial Update: Trial of Pevonedistat Plus Docetaxel in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial of pevonedistat plus docetaxel in previously treated advanced non-small cell lung cancer was terminated with results posted in…
-
CLINICAL_TRIALS trial_result · 2023-10-18Clinical Trial Update: Afatinib and Cetuximab in Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Positive Non-small-cell Lung Cancer [Phase 2]
Phase 2 clinical trial investigating afatinib and cetuximab for EGFR exon 20 insertion-positive non-small-cell lung cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-10-17Clinical Trial Update: A Study of Tislelizumab in Combination With Chemotherapy Versus Chemotherapy in Advanced Lung Cancer [Phase 3]
Phase 3 trial evaluating tislelizumab in combination with chemotherapy versus chemotherapy alone in advanced non-small cell lung cancer has …
-
CLINICAL_TRIALS trial_result · 2023-10-17Clinical Trial Update: A Study Osimertinib in Patients With Stage 4 Non-small Cell Lung Cancer With Uncommon EGFR Mutations [Phase 2]
Phase 2 trial of osimertinib in stage 4 non-small cell lung cancer with uncommon EGFR mutations has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-10-16Clinical Trial Update: Neoadjuvant Immunoradiation for Resectable Non-Small Cell Lung Cancer [Phase 2]
This is a Phase 2 neoadjuvant immunoradiation trial for resectable non-small cell lung cancer. The study was terminated, and results have be…
-
CLINICAL_TRIALS trial_result · 2023-10-12Clinical Trial Update: SH-1028 Tablets Versus Placebo as Adjuvant Therapy in Resected Stage II-IIIB NSCLC With Sensitizing EGFR Mutations [Phase 3]
Phase 3 clinical trial evaluating SH-1028 tablets versus placebo as adjuvant therapy in resected stage II-IIIB non-small cell lung cancer wi…
-
CLINICAL_TRIALS trial_result · 2023-10-11Clinical Trial Update: Pembrolizumab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-IIIB Non-Small Cell Lung Cancer [Phase 1]
Phase 1 study evaluating pembrolizumab with paclitaxel, carboplatin, and radiation therapy in stage II to IIIB non-small cell lung cancer ha…
-
CLINICAL_TRIALS trial_result · 2023-10-11Clinical Trial Update: Exhaled Breath Analysis to Predict Risk of Symptomatic Pneumonitis [NA]
Clinical trial investigating exhaled breath analysis to predict risk of symptomatic pneumonitis in patients with stage III non-small cell lu…
-
CLINICAL_TRIALS trial_result · 2023-10-03Clinical Trial Update: A Study of Mobocertinib in Japanese Adults With Non-Small Cell Lung Cancer [Phase 1]
Phase 1 study update of mobocertinib in Japanese adults with non-small cell lung cancer. Results have been posted and the study is currently…
-
CLINICAL_TRIALS trial_result · 2023-10-03Clinical Trial Update: The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy [Phase 2]
A Phase 2 clinical trial update focusing on personalized target therapy and immunotherapy approaches across breast and gastrointestinal canc…
-
CLINICAL_TRIALS trial_result · 2023-09-29Clinical Trial Update: Imaging of T-cell Activation With [18F]F-AraG in Advanced Non Small Cell Lung Cancer [Phase 2]
Phase 2 trial update investigating imaging of T-cell activation using [18F]F-AraG in advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2023-09-29Clinical Trial Update: Atezolizumab as Induction Therapy in Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial update of atezolizumab as induction therapy in non-small cell lung cancer (completed).
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Chemo-immunotherapy, Hypo-fractionated RT and Maintenance Immunotherapy for Stage III NSCLC. [Phase 2]
Phase 2 clinical trial update evaluating chemo-immunotherapy with hypo-fractionated radiotherapy followed by maintenance immunotherapy for S…
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Brigatinib in ALK-positive NSCLC Identified Via Blood-based Assays [Phase 2]
Phase 2 clinical trial evaluating brigatinib in ALK-positive non-small cell lung cancer identified via blood-based assays.
-
CLINICAL_TRIALS trial_result · 2023-09-22Clinical Trial Update: Adjuvant Befotertinib in Stage IB-IIIB Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations [Phase 3]
Phase 3 clinical trial evaluating adjuvant befotertinib in stage IB-IIIB non-small cell lung cancer with EGFR sensitive mutations is current…
-
CLINICAL_TRIALS trial_result · 2023-09-22Clinical Trial Update: Osimertinib and Bevacizumab as Treatment for EGFR-mutant Lung Cancers [Phase 1, Phase 2]
Phase 1/2 trial evaluating osimertinib plus bevacizumab in EGFR-mutant non-small cell lung cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Trial of Trametinib and Ponatinib in Patients With KRAS Mutant Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating trametinib and ponatinib in KRAS-mutant advanced non-small cell lung cancer has completed and results were posted…
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Phase III Study of SY-5007, a RET Inhibitor, in Patients With Locally Advanced or Metastatic RET Fusion-positive NSCLC [Phase 3]
Phase III trial update for SY-5007, a RET inhibitor, in locally advanced or metastatic RET fusion-positive non-small cell lung cancer; study…
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: A Study of Combination Therapies With Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating combination therapies with Viagenpumatucel-L (HS-110) in non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Almonertinib Combined With Anlotinib as First-line Treatment for Advanced Non-small Cell Lung Cance [Phase 3]
Phase 3 clinical trial updating first-line treatment of advanced non-small cell lung cancer using a combination of almonertinib and anlotini…
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: A Single Center, Single Arm Clinical Study on the Treatment of Advanced Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations and Failed EGFR TKIs With the Combination of Enrotinib and Paclitaxel Monoclonal Antibody [Phase 3]
A Phase 3 single-center trial evaluating enrotinib combined with a paclitaxel monoclonal antibody for advanced non-small cell lung cancer wi…
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Trial of Radiation and Gene Therapy Before Nivolumab for Metastatic Non-Small Cell Lung Carcinoma and Uveal Melanoma [Phase 2]
A Phase 2 trial evaluating radiation and gene therapy before nivolumab in metastatic non-small cell lung cancer and uveal melanoma was termi…